Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Biomerica Inc. BMRA

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.


Recent & Breaking News (NDAQ:BMRA)

Biomerica Reports 1st Quarter Fiscal 2019 Financials

GlobeNewswire October 16, 2018

Biomerica Announces Fiscal Year End 2018 Financial Results

GlobeNewswire August 30, 2018

Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea

GlobeNewswire August 2, 2018

Biomerica Announces First Patient Enrollment in Clinical Study for New Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy

GlobeNewswire June 25, 2018

Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board

GlobeNewswire April 19, 2018

Biomerica Announces Third Quarter Financial Results

GlobeNewswire April 17, 2018

Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

GlobeNewswire March 8, 2018

Mid-Afternoon Market Update: U.S. Stocks Turn Negative; Energizer Shares Spike Higher

Benzinga.com  January 16, 2018

Biomerica Announces Second Quarter Financial Results; Sales Up 12.7% for the Quarter

GlobeNewswire January 16, 2018

Mid-Day Market Update: SUPERVALU Drops After Q3 Results; AMERI Holdings Shares Climb

Benzinga.com  January 10, 2018

Mid-Morning Market Update: Markets Open Lower; Lennar Earnings Miss Expectations

Benzinga.com  January 10, 2018

China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

GlobeNewswire January 10, 2018

Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)

GlobeNewswire January 8, 2018

Biomerica Announces Enrollment of First Patient for H. Pylori Clinical Studies at the University of Southern California

Accesswire November 20, 2017

Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

GlobeNewswire November 7, 2017

Biomerica Reports 1st Quarter Fiscal 2018 Financials

GlobeNewswire October 17, 2017

Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test

GlobeNewswire September 12, 2017

Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year

GlobeNewswire August 30, 2017

Biomerica Announces Point of Care Product Distribution Agreement with a Multinational Pharmaceutical Company

GlobeNewswire August 16, 2017

Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017

Marketwired May 23, 2017